Csenge Advisory Group
- SEC CIK
- 0001715593
- Latest filing
- Aug 10, 2026
EVGN holding history
Evogene Ltd. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EVGN overviewAll 13F holders of EVGNFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −2,076−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q2 2024 | 20,762 | $13.5K | <0.1% | −10,000−32.5% | Reduced | Holders |
| Q1 2024 | 30,762 | $23.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 30,762 | $25.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 30,762 | $18.0K | <0.1% | +200+0.7% | Added | Holders |
| Q2 2023 | 30,562 | $32.7K | <0.1% | +6,000+24.4% | Added | Holders |
| Q1 2023 | 24,562 | $15.5K | <0.1% | −5,000−16.9% | Reduced | Holders |
| Q4 2022 | 29,562 | $20.7K | <0.1% | −2,400−7.5% | Reduced | Holders |
| Q3 2022 | 31,962 | $27.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 31,962 | $24.0K | <0.1% | −4,500−12.3% | Reduced | Holders |
| Q1 2022 | 36,462 | $47.0K | <0.1% | +7,762+27.0% | Added | Holders |
| Q4 2021 | 28,700 | $96.0K | <0.1% | −6,000−17.3% | Reduced | Holders |
| Q3 2021 | 34,700 | $91.0K | <0.1% | +6,000+20.9% | Added | Holders |
| Q2 2021 | 28,700 | $96.0K | <0.1% | +5,000+21.1% | Added | Holders |
| Q1 2021 | 23,700 | $110.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.